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Abstract  
 
Purpose Therapeutic recommendations of acute cholecystitis are not consistently 
implemented, which generates greater patient morbidity and higher health care costs. 
The aim of this article is to evaluate the burden of acute cholecystitis, to detect 
potentially modifiable variables and to propose a therapeutic strategy that will allow us 
to improve the quality of care.  
Methods We carried out a retrospective study of patients who were admitted to the 
hospital from January 2010 to December 2012 using a univariate analysis of parameters 
including the admitting department, age, treatment administered and length of stay. 
Results A total of 967 patients were admitted to the hospital with a diagnosis of acute 
cholecystitis,  692 (72%) to the Surgery department, 257 (26%) to Internal Medicine-
Digestive and 18 (2%) to other departments. 498 (51.5%) were operated on: 107 (21%) 
on an urgent basis, 111 (22%) at an early stage (<96 hours at diagnosis), 152 (30%) at a 
late stage (>96 hours at diagnosis) and 128 (26%) at a delayed date (other admission). 
Patients who were admitted into the surgery department were five times more likely to 
be operated on than patients admitted into other departments (p<0.01). Patients operated 
on at a late stage had a longer length of stay than early stage surgery patients (p<0.05) 
and than non operated ones (p<0.05). Patients <74 years old were more frequently 
operated than older ones (p<0.05).  
Conclusions The non-standardized treatment of acute cholecystitis causes high clinical 
and surgical variability, long average stay, more re-admissions and high hospital costs. 
Therefore, patients with a diagnosis of acute cholecystitis should be admitted to the 
Surgery department, thereby increasing the probability of receiving definite treatment. 
 
 
Introduction 
 
 Acute cholecystitis is a prevalent disease with a high socioeconomic impact. 
Approximately 10-15% of the population presents with cholelithiasis [1, 2]. Although 
the majority of cases are asymptomatic, complications such as biliary colic (1-4% 
yearly) or cholecystitis (20%) [3, 4] can develop. A third of the patients with acute 
cholecystitis can develop serious complications such as empyema, obstruction or 
cholangitis, which are especially common in elderly, diabetic or pregnant patients [5-7]. 
 Many authors show that early stage cholecystectomy in patients with acute 
cholecystitis is better than conservative treatment and results in lower patient morbidity 
and hospital costs, even with open surgery [8-14]. In spite of the scientific evidence, it 
is not a common practice. In the United States, only 30-40% of cholecystectomies are 
carried out at an early stage [15, 17]; 20-36% in the United Kingdom [17-19], 42% in 
Japan [20], 51% in Canada [21], 55% in Australia [22] and 26% in Spain [23]. 
However, after interviewing surgeons, all expressed a desire to carry out 
cholecystectomies at an early stage but do not do so due to organizational problems 
[24]. The idea that delayed cholecystitis is technically simpler due to reduced 
inflammation is not correct. In fact, the risk of wounding the main biliary tract is lower 
in early stage surgery [25], and the probability of conversion of this condition into a 
standardized early stage surgery is 8-16%, which is not significantly different from 
delayed surgery. Twenty five per cent of patients waiting for a delayed cholecystectomy 
are re-admitted and 18 % require urgent surgical intervention  [14, 25-27]. 
 This issue heavily impacts national health systems worldwide, totaling 6.3 
billion dollars in the USA [28] and 8.5 million pounds/year in UK [29, 30]. Early stage 
cholecystectomy leads to a higher quality of life for patients and a savings of $1000-
1400 per patient compared to delayed cholecystectomy [12, 29-31]. 
 The characteristics of our hospital are comparable to the characteristics of other 
tertiary level assistance centers with regard to the population served, the technological 
methods and the patient care. We analyzed the therapeutic strategy utilized in the last 
three years for patients diagnosed with acute cholecystitis to describe the current clinical 
guidelines and improve the quality of our patient care. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patients and methods 
 
 We conducted a retrospective study of patients admitted to our hospital from 
2010 to 2012 with a diagnosis of acute cholecystitis (n=967). For this purpose, we 
employed the 9th revision of the International Classification of Diseases clinical 
modification (ICD 9th, MC), 8th Spanish edition, utilized by the hospital's Clinical 
Records department to code all hospital admittances [32]. We utilized the codes 574.0 
and 574.1 (acute lithiasic cholecystitis), 574.3 (biliary duct obstruction with acute 
cholecystitis), 574.6 (acute lithiasic cholecystitis and choledocholithiasis) and 575.0 
(acute cholecystitis). We also utilized the HP-HIS corporate clinical software employed 
in the hospital to obtain the patients' clinical data.  
 Patients were admitted to the hospital via Emergency Services into the 
respective departments under the admitting doctor. The urgent and early stage surgeries 
were performed by 16 surgeons, and the delayed surgeries were performed by all 
department surgeons. We collected variables including age, admitting department, 
treatment administered, date when surgery was performed, length of stay and re-
admissions.  
 Statistical analyses To describe the study sample, we performed statistical 
testing using a univariate analysis. Parametric and non-parametric tests were performed 
according to the distribution of the variable of interest. For all continuous variables, 
mean values and their standard deviation (SD) and range were calculated using the 
SPSS software package (SPSS 19.0 Inc, Chicago, IL USA); The frequencies and 
percentages were calculated for categorical variables, utilizing Pearson's Chi-Squared 
test (or Fisher's exact test when appropriate) for categorical data analysis. In order to 
evaluate the statistical significance of differences observed between groups, the 
Student’s T and the Mann-Whitney U tests were used for continuous variables, 
depending on whether they displayed or not a normal distribution, respectively. For 
qualitative variables, the X2 test was applied ( SPSS 19.0 Inc, Chicago, IL USA). The 
hypothesis comparison was bilateral, with a 0.05 significance level. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 
 
 A total of 967 admissions with a diagnosis of acute cholecystitis were 
performed, 813 as first admission and 154 were re-admissions of the same diagnosis 
(16%). Patients were admitted from the Emergency Room into Surgery (n=692; 72%), 
Internal Medicine-Digestive (n=257; 26%) and to other departments, Hematology, 
Nephrology and Medical Oncology Services, (n=18; 2%). Given the unique 
characteristics and small numbers of patients admitted to "other departments", they were 
excluded from this analysis. The median age of the admitted patients was 78 years 
(range 17–103 years). The mean of stay for patients admitted due to this diagnosis was 
10.6 days (range: 1-104 days). Patients with sepsis secondary to acute cholecystitis 
(n=107, 11%) were urgently treated while patients with acute cholecystitis without 
sepsis (n=860, 89%) were treated by early surgery (≤96 hours at diagnosis-admission) 
(n=111, 11%) or conservative treatment (n=597, 62%) or late surgery (>96 hours after 
diagnosis-admission due to a poor clinical outcome with a median of 10.5 days (range: 
5-26 days) (n=152, 16%) without any definite criterion. Of those patients not operated 
on during the first admission (n=597), 128 (21%) were operated in elective form during 
other admission, 154 (26%) were readmitted and 72 (12%) had a subsequent emergency 
surgical intervention due to complications from acute cholecystitis (Figure 1). 
 When we analyze the post-ER admitting department and compare this category 
with the treatment carried out, we observe that patients admitted to Surgery have a five 
times higher probability of being operated on than Internal Medicine-Digestive patients 
(298 vs. 36, p<0.01). In addition, the patients admitted to Internal Medicine-Digestive 
have a longer preoperative stay (median 14 vs. 2 days; p<0.01), have a longer total stay 
(median 10 vs. 8 days; p<0.05) and are older (81 vs. 76 years; p<0.05) than the patients 
admitted to Surgery.  
 After comparing the medians of hospital stay and treatment administered, we 
find that patients undergoing early stage surgery had a shorter hospital stay than patients 
undergoing late surgery (median 8 vs. 10 days; p<0.05), while patients who did not 
undergo an operation had a shorter stay than patients who underwent a late surgery 
(median 8 vs. 10 days; p<0.05). Patients who underwent an early stage surgery had a 
stay length similar to those patients who were not operated on (median 8 days). If we 
compare age with the treatment administered, we find that the patients who were 
operated on are younger than the patients who were not operated on (median 74 vs. 80 
years; p<0.05) (Figure 2). In addition, the patients who underwent early stage surgery 
were younger than the patients who were not operated on (median 75 vs. 80 years; 
p<0.05), but no significant difference existed with regard to age between patients 
undergoing an early stage operation and patients undergoing a late stage operation 
(median 74 vs. 75 years; p>0.05). 
 Morbidity and mortality rates of early and late surgery are shown in Table 1. 
Although not significantly different, late surgery was more frequently complicated by 
bile leak than early surgery (11 vs. 7%, respectively). The median age of patients 
suffering from any type of complication was the same as of the global series (78 years 
in both). In contrast, mortality rate was higher in elderly patients (median age 85 years; 
ranging from 75 to 99 years), especially in those undergoing late surgery (vs. early 
surgery; p=.04). 
 Out of the 198 patients (21%) for whom conservative treatment failed, 152 
(77%) were operated later on and in the remaining 46 (23%) percutaneous gallbladder 
drainage was employed. 
 
 
 
 
Discussion 
 
 The treatment of acute cholecystitis may cause sepsis and lead to emergency 
surgery. However, in cases that do not lead to sepsis in the patient, current clinical 
guideline recommendations have not been developed in the majority of hospitals.   
In our institution patients admitted to the Surgery department receive the 
standard treatment at present [10, 11] with a higher probability than patients who are 
admitted to another department. The literature we reviewed does not collect information 
regarding the admitting department of patients (medical or surgical), but we confirm its 
significance. Patients with a diagnosis of acute cholecystitis should be admitted the 
Surgery department, thereby increasing the probability of receiving definitive treatment.  
 We medically treat 49% of cases due to comorbidity, development time of the 
condition, organizational problems or instruction from the doctor responsible for the 
patient. Considering all of the randomized prospective studies published to date 
regarding this treatment and the current clinical guideline recommendations, the 
treatment of acute cholecystitis should invariably be surgical, except for very high-risk 
cases or patient refusal. Delayed surgery is not recommended because further increasing 
the morbidity, total stay and cost of treatment. 
 Age affects the treatment received. In our series we operate few patients over 74 
years old (figure 2). Life expectancy in developed countries is high and is on the rise. In 
our setting, life expectancy in women is 86.7 years and in men is 80.5 years, with an 
increase of 3 years in the last decade [33]. This increase that we are more often dealing 
with elderly patients who have a combination of diseases including acute cholecystitis, 
for which we should carefully analyze the surgical risk and select the better treatment at 
the time of operation with/without percutaneous cholecystectomy, individualizing 
treatment in each case. We do not calculate anesthetic-surgical risk prior to choosing a 
therapeutic strategy. However, we do systematically utilize the ASA classification prior 
to a planned delayed surgery. In the Tokyo clinical guidelines, organic dysfunction 
scales are employed (Marshall, SOFA) to evaluate grade III acute cholecystitis [34]. In 
the therapeutic algorithms of these same guidelines, biliary drainage is recommended 
for patients with grade II and III acute cholecystitis and high surgical risk [35-36]. Some 
authors recommend grading acute cholecystitis and employing the ASA, POSSUM, P-
POSSUM, APACHE II classification system or other anesthetic risk scales in patients 
with moderate-severe acute cholecystitis who are at high risk (ASA> 3, APACHE> 12), 
as their morbidity is higher, and their mortality surpasses 15%  [37-39]. In critically ill 
patients, although percutaneous gallbladder drainage is recommended due to its clinical 
efficacy and simplicity, the morbidity associated with this procedure is high. At present, 
controversy regarding this treatment exists, and no evidence indicates its use [40-42]. 
Multicenter randomized studies are currently being conducted that will contribute 
clarity in this aspect [43]. Due to these restrictions and to differences found regarding 
anesthetic criteria, we believe that anesthetic-surgical risk should be evaluated in all 
patients using a risk scale that is independent of the degree of acute cholecystitis. In this 
way, we would avoid administering conservative treatment to patients instead of 
surgical procedures. In our hands, conservative treatment fails in approximately 21% of 
patients. Therefore, we recommend that patients with the suspected diagnosis of acute 
cholecystitis would be assessed by an experienced surgeon before rendering the definite 
treatment employing a risk score scale. Patients with an estimated mortality <15% could 
be considered candidates to surgical treatment. 
 After evaluating the surgery performed on our patients, we observed that 11% 
were operated on urgently. This treatment is recommended for patients with Tokyo 
grade III cholecystitis, who comprise 1-6% of all patients [32]. It is possible that in our 
center we are performing urgent surgeries in some patients who do not actually require 
it, resulting in an overload of urgent care activity and consequently long wait times. A 
third of the patients undergoing an operation, 16% of all patients admitted with this 
diagnosis, were operated on at a late stage. The technical difficulty of cholecystectomies 
increases with the increasing number of days that have passed since the start of 
symptoms [26], which also increases length of stay and cost. In addition, delayed 
surgery causes higher mortality and bile leak in our series. For these reasons, late 
surgery should be reserved only for high surgical risk patients having a poor clinical 
response to medical treatment and should always performed by surgeons with 
experience with this type of intervention [44-45]. More carefully selecting the type of 
treatment given immediately after the time of admission should reduce this number.  
 Employing a retrospective study of patient care, we verified that disparities exist 
between patients who are admitted with a diagnosis of acute cholecystitis. We also 
found that we do not adequately evaluate the severity of this condition and often do not 
perform the appropriate surgery according to clinical guidelines at the time of decision-
making. In consequence, we are not able to offer our patients the best possible treatment 
with our currently available resources, the hospital stay is longer, and the price of 
hospital care is higher.  
 We propose that patients with a diagnosis of acute cholecystitis be admitted to 
Surgery department and that they be selected based on acute cholecystitis severity 
criteria, that risk be calculated using a risk scale (P-POSSUM, ACS NSQIP), that we 
apply the therapeutic algorithms recommended by current clinical guidelines and that 
patients be treated by surgeons who have experience with this type of intervention to 
reduce morbidity, re-admission, average stay and hospital costs.  
 With the limitations of a retrospective study, we can conclude from our 
observations that the non-standardized treatment of cholecystitis causes high clinical 
and surgical variability, long average stay, more re-admissions and high hospital costs. 
Late surgery has higher mortality and bile leak than early one. Therefore, we propose 
the development of a standardized strategy for the treatment of acute cholecystitis. 
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Legend to figures 
 
Figure 1. Patients admitted (n=967) with diagnosis of acute cholecystitis and treatment 
received during 2010, 2011 and 2012. 
 
No surgery: patients with medical treatment. Urgent surgery: performed on the same 
day as admission. Early stage surgery:  performed within the first four days of 
admittance. Late stage surgery: performed at a later time but during the same admission. 
Elective surgery: performed during another admission. 
 
 
 
Figure 2: Treatment of patients admitted and their relationship with age. The green line 
represents the group of patients undergoing surgery, whereas the blue line refers to the 
medically treated patients. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
